-
FDA Fast Tracks Suvodirsen Designation
The U.S. Food and Drug Administration has granted fast track designation to suvodirsen as a treatment for people with Duchenne muscular dystrophy (DMD). Read more about the decision here.
Are you excited about this news?
Sorry, there were no replies found.
Log in to reply.